English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 22 March 2021, 08:00 HKT/SGT
Share:
    

Source: Agilex Biolabs
Agilex Biolabs Showcases Advanced Immunoassay and Immunobiology Services at Bio-Europe Spring 2021

ADELAIDE, AUS, Mar 22, 2021 - (ACN Newswire) - Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, announced it will showcase its world-class immunoassay and immunobiology services for regulated bioanalysis at Bio-Europe 2021.

Dr Kurt J. Sales Agilex Biolabs' Director Immunoassay said:

"Our experienced team can develop or transfer a method for any biologic to support pre-clinical GLP or clinical studies. Our world-class laboratories feature state-of-the-art equipment including Gyrolab Xplore, MSD Quickplex 120, Luminex Magpix, BD FACSymphony A3 flow cytometer and soon to be released, digital droplet quantitative real-time RT-PCR. Our scientists have expertise and experience to solve the most complex immunogenicity and drug tolerance issues, often encountered in immuno-oncology studies in both an early phase and later phase setting."

Agilex Biolabs also features a rebate of up to 43.5% on clinical trial bioanalytical services spend as part of the Australian Government clinical trial attraction program.

Learn more: Take a briefing with our Scientists at Bio-Europe via PartneringOne. Login Here https://informaconnect.com/bio-europe-virtual/

Or Book a Briefing with us before you start your next clinical trial. https://calendly.com/agilexbiolabs/15min

Agilex Biolabs also has the leading certifications including OECD GLP Recognition with NATA (Australian Government OECD GLP Compliance monitoring authority) and ISO 17025 Accreditation for global recognition.

Australian clinical trials have remained open for business and Agilex Biolabs is a designated essential service so clients can be assured of study continuity.

Australia has led the world in keeping COVID-19 numbers down to almost zero across the country by acting swiftly to minor outbreaks.

The company has recently expanded its labs by more than 30% to accommodate biotech demand from APAC, EU and the USA. Watch the New Labs Walkthrough Video Here https://www.agilexbiolabs.com/new-labs-video

Agilex Biolabs has more than 100 staff which includes 75 dedicated laboratory staff.

About Agilex Biolabs https://www.agilexbiolabs.com/

Agilex Biolabs, Australia's leading bioanalytical laboratory, has more than 24 years' experience in performing regulated bioanalysis, including quality method development, method validation and sample analysis services. We have successfully supported hundreds of preclinical and clinical trials around the world where customers choose Australia for the streamlined regulatory process and access to the world's most attractive R&D rebate of more than 40% on clinical trial work conducted in Australia.

We offer services for both small molecules and biologics for PK, immunogenicity (PD) and biomarker bioanalysis utilising the two platforms of LC-MS/MS and Immunoassay.

Agilex Biolabs Media Contact:
Kate Newton
Media@AgilexBiolabs.com

Topic: Press release summary
Source: Agilex Biolabs

Sectors: Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Agilex Biolabs Releated News
Sept 1, 2021 11:00 HKT/SGT
애질렉스 바이오랩스, 호주 내 신속한 백신 개발 관련 첫 웹세미나를 위해 엔드포인트 뉴스와 파트너십 체결
Aug 31, 2021 06:00 HKT/SGT
Agilex Biolabs 与 Endpoints News 合作举办澳大利亚第一次关于快速疫苗开发的网络研讨会
Aug 31, 2021 06:00 HKT/SGT
Agilex Biolabs 與 Endpoints News 合作舉辦澳大利亞第一次關於快速疫苗開發的網絡研討會
Aug 30, 2021 12:00 HKT/SGT
Agilex BiolabsがEndpoints Newsと提携し、オーストラリアにおける迅速なワクチン開発に関する初のウェビナーを開催
Aug 26, 2021 13:00 HKT/SGT
Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia
More news >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575